Navigation Links
First Clinical Experience With Soliris(R) in Treating Patients With Two Rare Complement-Mediated Diseases Presented at ASH Annual Meeting
Date:12/7/2008

the mechanisms at work in these disorders lead us to believe that there are strong scientific rationales for undertaking controlled clinical trials to investigate the role of complement inhibition in these two conditions," said Leonard Bell, M.D., Chief Executive Officer of Alexion. "As previously announced, we are working closely and urgently with clinical experts from Europe and North America to design clinical trials of eculizumab for the treatment of aHUS and CAD."

Initial Experience with Eculizumab in aHUS

A poster titled "Successful Treatment of Atypical Hemolytic Uremic Syndrome with the Complement Inhibitor Eculizumab" was presented today at the ASH annual meeting by Dr. Jens Nuernberger of the Department of Nephrology at University Duisburg-Essen in Essen, Germany.

Dr. Nuernberger and his colleagues investigated the potential effect of eculizumab in two patients with aHUS, a rare disease usually caused by a genetic mutation in the complement system. In patients with aHUS, this defect results in hemolysis, formation of tiny blood clots (microvascular thrombosis) and inflammation of blood vessels, often causing acute kidney injury and progressing to end-stage kidney disease. Those who survive aHUS often live with irreversible kidney disease and are dependent upon dialysis to stay alive.

"Our first clinical experience with eculizumab in patients with aHUS is very promising, especially given the devastating nature of this disease and the lack of effective treatments," said Dr. Nuernberger. "Initial data suggest that eculizumab reduced hemolysis, microvascular thrombosis, and blood vessel inflammation, thereby appearing to improve the course of aHUS. If clinical trials confirm these results, eculizumab may then improve our ability to care for these patients."

Initial Experience with Eculizumab in CAD

A poster titled "Long-term Efficacy of the Terminal Comple
'/>"/>

SOURCE Alexion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease
2. FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder
3. Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351
4. Alba Therapeutics Announces Enrollment of Its First European Patient in Global Phase IIb Study of Larazotide Acetate for Treatment of Active Celiac Disease
5. Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C
6. Diagenic Announces Launch of First Breast Cancer Gene-Expression Blood Test
7. Zevalin(R) Following Short-Course Chemotherapy with CHOP + Rituximab (CHOP-R) Doubles Complete Remission Rate in First-Line Treatment of Follicular Non- Hodgkins Lymphoma
8. Celladon Announces Presentation of Clinical Data From First-in-Human MYDICAR(R) Trial for Advanced Heart Failure at American Heart Association Scientific Sessions
9. Sequoia Pharmaceuticals Presents In Vitro and First-in-Human Data Supporting Further Development of SPI-256, a Novel Investigational Protease Inhibitor
10. ULURU Inc. Announces the Commencement of First Clinical Study Using Altrazeal(TM) Silver
11. First Town Hall Meeting on Inequities in Clinical Trials to Take Place at the Harlem Hospital Center on October 20
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... , May 1, 2015  An effective advisory ... provide non-binding but informed guidance to pharmaceutical organizations ... on investment, it is important for leaders to ... resources. Research and consulting leader ... assist pharmaceutical and medical device executives in identifying ...
(Date:5/1/2015)... HILL, N.C. , May 1, 2015 ... payers for its high price but manufacturer Gilead Sciences ... strategic worldwide pricing, and effective public relations campaigns. ... promise of less severe side effects propelled the drug ... of 2014, the therapy,s first quarter on the market. ...
(Date:5/1/2015)...   Intarcia Therapeutics, Inc. today announced the ... President, Human Resources, reporting directly to Kurt Graves ... key member of the senior leadership team, Mr. Brady ... to assure the Company advances its business, brings in ... values and its dynamic culture. Another essential goal for ...
Breaking Medicine Technology:New Study Presents Insights to Advisory Board Effectiveness in the Pharmaceutical Sector 2New Study Examines Success Lessons of Sovaldi's and Harvoni's Blockbuster Launches 2Intarcia Appoints James P. Brady Vice President, Human Resources 2Intarcia Appoints James P. Brady Vice President, Human Resources 3Intarcia Appoints James P. Brady Vice President, Human Resources 4
... women and men has a bleeding disorder. However, 75 percent still ... it take to Close the Gap? On World ... the message to "Close the Gap" in care around the world. ... available for all globally. Many are unaware that if ...
... 2012  Mastech Holdings, Inc. (NYSE Amex: ... Technology and Specialized Healthcare Staffing services, has scheduled a conference call ... March 31, 2012.  The conference call will occur ... Eastern Time and will be hosted by Mr. ...
Cached Medicine Technology:World Hemophilia Day -- April 17 2Mastech Holdings, Inc. to Discuss First Quarter 2012 Financial Results on April 25, 2012 2
(Date:5/2/2015)... 03, 2015 As one of only ... prestigious Safety and Health Achievement and Recognition Program (SHARP) ... be chosen by the Illinois Department of Labor to ... and maintained SHARP certification by the Occupational Safety and ... Essentra has continued to meet or exceed all of ...
(Date:5/2/2015)... (PRWEB) May 02, 2015 Vancouver fencing company, ... now provide valuable advice to prospective clients related to their ... looking to install railings around their decks and patios. While ... questions that pop up once the person rolls up their ... of installing a railing in finding a gate that matches ...
(Date:5/2/2015)... CA (PRWEB) May 02, 2015 ProText Kinetic ... for use in Final Cut Pro X. ProText Kinetic ... use in Final Cut Pro X . Easily ... keyframe with Pixel Film Studios' ProText Kinetic 2. , Using ... Start by staggering two ProText Kinetic presets in the FCPX ...
(Date:5/2/2015)... (PRWEB) May 02, 2015 We are ... The Delray Recovery Center as one of the Top ... known in the addiction treatment field for their ethics ... to innovate and to continue their educational efforts. The ... workplace environment, never forgetting their purpose – to help ...
(Date:5/2/2015)... Liverpool, Ohio (PRWEB) May 02, 2015 ... East Liverpool City Hospital (ELCH) gathered to celebrate improvements ... of River Valley Health Partners (RVHP), had zero acquired ... zero urinary catheter associated infections. ELCH was also recently ... , The management team at ELCH credited the teamwork ...
Breaking Medicine News(10 mins):Health News:Essentra Specialty Tapes is Selected to Host Gov. Rauner and the Workers' Memorial Day Celebration 2Health News:Essentra Specialty Tapes is Selected to Host Gov. Rauner and the Workers' Memorial Day Celebration 3Health News:Professional Staff at QS Fencing Company Now Provides Advice on Railings and Gates 2Health News:Pixel Film Studios Announced the Release of Protext Kinetic 2 for FPCX. 2Health News:The Delray Recovery Center Named 2015 Top Workplace 2Health News:East Liverpool City Hospital Celebrates Patient Care Improvements 2
... babies aren,t infected, study finds , WEDNESDAY, June 17 ... all pregnant women for group B streptococcal disease have ... Eighty-five percent of women in the United States are ... , "This paper highlights an important public health success ...
... ... while driving, an act praised by New York car accident lawyer David Perecman. , ... New York, NY (PRWEB) June 18, 2009 -- Stirring ... 49 people after the driver ran a red light while texting on his cell phone. The ...
... Pablo CEU, a major academic and research institution in ... chief executive officer of the American Association for Cancer ... her exceptional contributions to cancer research and leadership of ... those suffering from cancer. "Margaret Foti exemplifies ...
... Services (PH&S) Enters into Three-Year Agreement with Varian ... Varian Medical Systems (NYSE: VAR ) and ... agreement for Varian to provide PH&S treatment centers with ... covers Varian,s state-of-the-art equipment and software. , , ...
... WASHINGTON, June 17 Health-privacy advocates and patient-choice supporters will ... Club in Washington, DC on Thursday, June 18 at 9:00 ... , , STRENGTHEN HEALTH-PRIVACY RIGHTS: Which bills will make ... Identifier (UHI) to tag and track them from cradle to ...
... Two new studies published by neurologists at Columbia University ... more vigilant monitoring for seizure activity among intensive care ... typically unrecognized. These subtle seizures may be affecting patients, ... disability. Published in recent issues of the ...
Cached Medicine News:Health News:Group B Strep Screening Guidelines Sparing Newborns 2Health News:Group B Strep Screening Guidelines Sparing Newborns 3Health News:No Matter the Vehicle, Sending Text Messages While Driving Increases Risk of Accidents, Warns New York Auto Accident Lawyer 2Health News:No Matter the Vehicle, Sending Text Messages While Driving Increases Risk of Accidents, Warns New York Auto Accident Lawyer 3Health News:AACR CEO Margaret Foti receives honorary M.D. from the University of San Pablo CEU 2Health News:AACR CEO Margaret Foti receives honorary M.D. from the University of San Pablo CEU 3Health News:Leading Healthcare Group Selects Varian Medical Systems to Supply Cancer Treatment Technology for Treatment Centers Across the Western United States 2Health News:Leading Healthcare Group Selects Varian Medical Systems to Supply Cancer Treatment Technology for Treatment Centers Across the Western United States 3Health News:New findings encourage more vigilant monitoring of seizure activity among intensive care patients 2Health News:New findings encourage more vigilant monitoring of seizure activity among intensive care patients 3
The KAT-Quick Malaria test was designed for the diagnosis of Malaria, in laboratories, the home and for medical kits when travelling into malaria regions....
Malaria P.f. Rapid Test Device...
Core Malaria Pf is a rapid self performing, qualitative, two site sandwich immunoassay for the determination of P. falciparum specific histidine rich protein 2 (Pf HRP-2) in whole blood samples...
... The NOW® Malaria Test is a field ... a Malaria infection. It is intended for the ... antigen and an antigen that is common to ... (P.f.), Plasmodium vivax (P.v.), ...
Medicine Products: